Both in Pharmaceuticals
Decoy Therapeutics vs Lakewood-Amedex Biotherapeutics
Over the past year DCOY returned −59.9% and LABT returned −91.0%; their daily moves had a correlation of 0.26.
DCOY −59.9% LABT −91.0%Growth of $1, one year, split-adjusted
| Metric | DCOY | LABT |
|---|---|---|
| Price | $1.07 | $0.2000 |
| Market cap | $701.0K | $473.9K |
| Today | −13.01% | −15.72% |
| 1 month | −42.3% | −78.5% |
| 6 months | −81.9% | — |
| Year to date | — | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1042.8% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.3M | $4.6M |
| Dividend yield | — | — |
| Volatility (60d) | 121.8% | — |
| Short % of float | 16.8% | 5.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).